Evidence map›Paper›PMID 29890748›Full record

ArticleBehavioral sciences (Basel, Switzerland)2018

Oxidative Stress in Patients with Drug Resistant Partial Complex Seizure.

Lourdes Lorigados Pedre, Juan M Gallardo, Lilia M Morales Chacón, Angélica Vega García, Monserrat Flores-Mendoza, Teresa Neri-Gómez, Bárbara Estupiñán Díaz, Rachel M Cruz-Xenes, Nancy Pavón Fuentes, Sandra Orozco-Suárez

Open access · goldAbstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Effects of long-termSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  5. Article
  6. Review
  7. Crosstalk between neuroinflammation and oxidative stress in epilepsy.Frontiers in cell and developmental biology · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Lourdes Lorigados PedreImmunochemical Department, International Center for Neurological Restoration, 25th Ave, Playa, 15805 Havana, Cuba. lourdesl@neuro.ciren.cu.ORCID 0000-0003-4913-0706
Juan M GallardoMedical Research Unit in Nephrological Diseases, Specialty Hospital, National Medical Center "XXI Century", IMSS, 06720 Mexico City, Mexico. jmgallardom@gmail.com.
Lilia M Morales ChacónClinical Neurophysiology Lab., International Center for Neurological Restoration, 11300 Havana, Cuba. lily@neuro.ciren.cu.ORCID 0000-0003-0205-0733
Angélica Vega GarcíaMedical Research Unit in Nephrological Diseases, Specialty Hospital, National Medical Center "XXI Century", IMSS, 06720 Mexico City, Mexico. ange_li_k@hotmail.com.
Monserrat Flores-MendozaMedical Research Unit in Nephrological Diseases, Specialty Hospital, National Medical Center "XXI Century", IMSS, 06720 Mexico City, Mexico. moonsefm@hotmail.com.
Teresa Neri-GómezNanomaterials Laboratory, Research Center in Health Sciences, Autonomous University of San Luis Potosí, 78300 San Luis Potosi; Mexico. tnerigomez@gmail.com.ORCID 0000-0003-0761-5350
Bárbara Estupiñán DíazMorphological Laboratory, International Center for Neurological Restoration, 11300 Havana, Cuba. baby@neuro.ciren.cu.
Rachel M Cruz-XenesBiology Faculty, University of Havana, 10400 Havana, Cuba. rachel.cruz@fbio.uh.cu.
Nancy Pavón FuentesImmunochemical Department, International Center for Neurological Restoration, 25th Ave, Playa, 15805 Havana, Cuba. nancy@neuro.ciren.cu.
Sandra Orozco-SuárezMedical Research Unit in Nephrological Diseases, Specialty Hospital, National Medical Center "XXI Century", IMSS, 06720 Mexico City, Mexico. sandra.orozcos@imss.gob.mx.ORCID 0000-0001-5289-8500
International Center of Neurologic Restoration · CUMexican Social Security Institute · MXAutonomous University of San Luis Potosí · MXUniversity of Havana · CU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress (OS) has been implicated as a pathophysiological mechanism of drug-resistant epilepsy, but little is known about the relationship between OS markers and clinical parameters, such as the number of drugs, age onset of seizure and frequency of seizures per month. The current study’s aim was to evaluate several oxidative stress markers and antioxidants in 18 drug-resistant partial complex seizure (DRPCS) patients compared to a control group (age and sex matched), and the results were related to clinical variables. We examined malondialdehyde (MDA), advanced oxidation protein products (AOPP), advanced glycation end products (AGEs), nitric oxide (NO), uric acid, superoxide dismutase (SOD), glutathione, vitamin C, 4-hydroxy-2-nonenal (4-HNE) and nitrotyrosine (3-NT). All markers except 4-HNE and 3-NT were studied by spectrophotometry. The expressions of 4-HNE and 3-NT were evaluated by Western blot analysis. MDA levels in patients were significantly increased (

Indexed as

3-NT4-HNEAGEsdrug-resistant epilepsyMDAnitric oxideoxidative stressredoxSODvitamin C

Identifiers

PMID29890748
PMCPMC6027168
OpenAlexW2806401092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.